Skip to content

Median Effective Dose and 95% Effective Dose of Oliceridine for Analgesia in Patients Undergoing Induced Abortion When Combined with Ciprofol

Median Effective Dose and 95% Effective Dose of Oliceridine for Analgesia in Patients Undergoing Induced Abortion When Combined with Ciprofol

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121291
Enrollment
Unknown
Registered
2026-03-27
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Induced Abortion

Interventions

Test group:The patient was placed in the lithotomy position. Oliceridine was administered intravenously, followed by slow intravenous injection of ciprofol 0.4 mg/kg. A vaginal speculum was inserted a
if a negative response occurred, the dose was decreased by 0.002 mg/kg.

Sponsors

General Hospital of Northern Theater Command
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. ASA grade I or II; 2. Aged 20–45 years; 3. BMI 18.5–26.0 kg/m²; 4. Transvaginal ultrasound confirmed early intrauterine pregnancy and scheduled for painless induced abortion under general anesthesia; 5. Signed informed consent form.

Exclusion criteria

Exclusion criteria: 1. Acute upper respiratory tract infection; 2. Full stomach (not fasting as required); 3. Severe dysfunction of vital organs, including severe cardiac, pulmonary, hepatic, or renal impairment; 4. Hypertension or cardiac arrhythmia; 5. Anticipated difficult airway; 6. Long-term use of psychotropic medications or presence of cognitive dysfunction; 7. Allergy or contraindication to any medication used in the planned anesthesia regimen; 8. Expected or actual surgical duration > 10 minutes.

Design outcomes

Primary

MeasureTime frame
A positive response was defined as the occurrence of body movement during cervical dilatation (including frowning, moaning, or involuntary limb movement), or an increase in heart rate (HR) or mean arterial pressure (MAP) exceeding 20% of the baseline value.;ED50;ED95;

Secondary

MeasureTime frame
Heart rate;Mean Arterial Pressure (MAP);Oxygen Saturation (SpO2);Duration of surgery;Duration of anesthesia;Recovery time;Ciprofol consumption;Pain VAS score at 15 minutes after awakening;

Countries

China

Contacts

Public ContactLi Lin

Department of Anesthesiology, General Hospital of Northern Theater Command

lilinslashofmine@qq.com+86 153 0402 6349

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 4, 2026